CPhI: Manufacturing Ingredients Zone

In North America, approximately 4,100 small molecule drugs are in various stages of development

Be counted among the leaders in API and Excipients! The pharmaceutical excipients market is expected to grow significantly over the next few years. By 2021, the market is projected to be worth $8.1B with a growth of 6.1% CAGR. The biopharma pipeline alone has 5,000 new medicines in development around the world with 3,400 compounds being studied in the US, more than any other region.

Huge opportunities for growth exist in the North America, and with more than 3,000 companies in the immediate vicinity of Philadelphia, CPhI North America is the perfect place for you to create new partnerships and to grow your business.   

 

Pharma Phacts

  • CPhI North America will deliver companies interested in API and Excipients.
  • 45% of the attendees at CPhI Worldwide in 2015 were focused on APIs
  • 16% of the attendees at CPhI Worldwide in 2015 were interested in Excipients / Formulation.

 

Companies who are already participating in CPhI North America include:

  • Abbvie
  • Acebright
  • ACIC
  • Ampac Fine Chemical
  • Aptar Pharma
  • Ashland
  • BioSpectra
  • Catalent
  • Evonik